Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes

Feb.03
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s Federal Public Prosecutor’s Office (MPF) and health regulator Anvisa signed a cooperation protocol to strengthen enforcement against electronic smoking devices (DEFs) and expand health-risk awareness campaigns.

Key Points

 

  • MPF and Anvisa formed a cooperation framework to strengthen vape enforcement and risk communication.
  • The key goal is full compliance with Anvisa’s RDC 855/2024 vape ban.
  • The agencies will share technical intelligence from inspections in physical and digital environments and run joint actions.
  • MPF will pursue civil/criminal accountability and coordinate with other oversight bodies; Anvisa will provide technical-scientific support and share surveillance data.
  • Bimonthly coordination meetings; 60-month term; no funding transfers.

 


 

2Firsts, Feb 3, 2026

 

According to Brazil’s Federal Public Prosecutor’s Office (MPF), the MPF and the National Health Surveillance Agency (Anvisa) signed a protocol of intentions to intensify enforcement against electronic smoking devices (DEFs) and develop public awareness campaigns on health risks.

 

The cooperation was enabled by the Health Commission linked to the MPF’s First Chamber for Social Rights and Oversight of Administrative Acts (1CCR). The protocol was signed by MPF Secretary-General Eliana Torelly and Anvisa Director-President Leandro Safatle.

 

The agreement seeks to ensure full compliance with Anvisa’s RDC No. 855/2024, which prohibits the manufacturing, importation, commercialization, distribution, storage, transportation, and advertising of e-cigarettes across Brazil. The cooperation will be carried out through the sharing of technical information from inspections in both physical locations and online environments, along with coordinated joint actions.

 

Under the division of responsibilities, MPF will pursue civil and criminal accountability for identified violations and coordinate with other control bodies. Anvisa will provide technical-scientific support and share data related to actions taken by Brazil’s National Health Surveillance System.

 

To align strategy, the institutions will hold bimonthly meetings. The protocol is valid for 60 months and may be extended; it предусматривает no transfer of financial resources between the parties.

 

The protocol also reflects MPF’s earlier position. In 2024, MPF issued a technical note on Bill No. 5,008/2023, which proposed legalizing and regulating these devices, recommending against its approval on the grounds that it would weaken Brazil’s national tobacco control policy and violate the precautionary principle. The note emphasized maintaining and strengthening the current prohibition framework, ramping up enforcement, tightening import controls to curb illicit trade, and pairing those measures with education campaigns, systematic monitoring, and cessation-focused strategies.

 

Image source: Federal Prosecution Service of Brazil (MPF)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
VAPORESSO has listed the LUXE X3, a new addition to its LUXE X series, on its official website. The device features a 2,600mAh built-in battery, adjustable 5–45W output and a 0.8-inch digital display, and comes with a 5ml pod (2ml for the TPD version). The LUXE X3 has also appeared on some UK and US online retailers for pre-order, with prices below the company’s stated MSRP of $37.9.
Jan.19 by 2FIRSTS.ai
MEPs seek Commission answers over EU trade officials’ contacts with PMI
MEPs seek Commission answers over EU trade officials’ contacts with PMI
POLITICO reports that five members of the European Parliament’s health committee want to invite the European Commission to answer questions about its contacts with Philip Morris International (PMI), following a POLITICO and The Examination investigation into extensive meetings between EU trade officials and tobacco lobbyists.
Jan.15 by 2FIRSTS.ai
Germany Sees 18.2% Jump in Taxed Tobacco Substitutes in 2025, Including E-liquids
Germany Sees 18.2% Jump in Taxed Tobacco Substitutes in 2025, Including E-liquids
Germany’s Federal Statistical Office (Destatis) said 66.4 billion cigarettes were taxed in 2025, up 0.2% from 2024, while long-term volumes have more than halved since 1991 and per-capita consumption fell to 795 cigarettes. Taxed tobacco substitutes such as e-cigarette liquids reached 1.5 million liters, up 18.2% year on year.
Jan.26 by 2FIRSTS.ai
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
South Korea Postal Service Launches Heated Tobacco Device Recycling Program Through Nationwide Post Offices and Mailboxes
Korean postal system launches nationwide heated tobacco device recycling through post offices and mailboxes, aiming to increase recycling rates.
Feb.10 by 2FIRSTS.ai
Indonesia’s Vape Excise Revenue Rises 7.38% in 2025 to $170.4M Amid Broader Tobacco Excise Decline
Indonesia’s Vape Excise Revenue Rises 7.38% in 2025 to $170.4M Amid Broader Tobacco Excise Decline
Indonesia’s customs data show vape (REL) excise revenue reached Rp 2.84 trillion in 2025 (≈$170.4 million), up 7.38% year over year. The gain came even as overall tobacco excise revenue declined. Minimum retail price benchmarks (HJE) for vape products rose in 2025, while excise rates remained unchanged from 2024; open-system e-liquids accounted for the largest share of revenue.
Jan.27 by 2FIRSTS.ai
Five Inner West Sydney shops shut for 90 days after 780,000 illicit cigarettes and 2,200 illegal vapes seized
Five Inner West Sydney shops shut for 90 days after 780,000 illicit cigarettes and 2,200 illegal vapes seized
NSW Health has shut down five Inner West Sydney stores for 90 days after a major seizure of illicit cigarettes and illegal vapes, with two additional premises in Northern NSW also served closure notices. The action forms part of a broader crackdown that has seen 66 stores closed since new laws took effect in late 2025, with NSW Health warning further enforcement — including prosecution — may follow.
Feb.09 by 2FIRSTS.ai